Moraga, CA, United States of America

Paul Scott Eastman

This inventor holds 1 USPTO granted patent. Top assignee: Gen-Probe, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Scott Eastman. Retrieved from https://idiyas.com/inventor/paul-scott-eastman-ml1mfwgi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul Scott Eastman: Innovator in Nucleic Acid Detection

Introduction

Paul Scott Eastman is a notable inventor based in Moraga, California. He has made significant contributions to the field of molecular biology, particularly in the detection and measurement of spliced nucleic acids. His work has implications for medical diagnostics and research.

Latest Patents

Eastman holds a patent titled "Methods for detecting and measuring spliced nucleic acids." This invention includes methods for detecting and measuring the amount of one or more species of bcr-abl spliced mRNA present in a sample, following nucleic acid amplification. He has 1 patent to his name, showcasing his innovative approach to addressing complex biological challenges.

Career Highlights

Eastman is currently employed at Gen-Probe, Inc., a company known for its advancements in molecular diagnostics. His role at Gen-Probe allows him to apply his expertise in nucleic acid technologies, contributing to the development of diagnostic tools that can improve patient outcomes.

Collaborations

One of his notable collaborators is Richard C. Harvey. Their partnership exemplifies the collaborative nature of scientific research, where diverse expertise can lead to groundbreaking innovations.

Conclusion

Paul Scott Eastman is a distinguished inventor whose work in nucleic acid detection has the potential to transform medical diagnostics. His contributions reflect the importance of innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…